TCM has received an approval to negotiate, finalize the terms and conditions of the proposed potential acquisition of Edayar Zinc shares within the company and sign on behalf of the Company the final ‘Term Sheet’ for the said potential acquisition and also in all necessary documents.
The Board of the company at their meeting held on February 12, 2019, authorized Joseph Varghese, Managing Director to negotiate, finalize the same.
TCM is engaged in the manufacture of Potassium Chlorate – a vital raw material for the match Industry.
| Company Name | CMP |
|---|---|
| BASF India | 3653.10 |
| Tata Chemicals | 704.05 |
| SRF | 2464.40 |
| Pidilite Inds. | 1390.15 |
| Deepak Nitrite | 1537.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: